Screening for Diseases: Current Controversies

Wednesday, Nov. 28, 4:30-6:00 p.m. | E450A

A panel of expert speakers reviews the benefits, harms and controversies associated with screening for lung and breast cancer.

Speaker Information:

  • Elizabeth S. Burnside, MD, MPH, University of Wisconsin, Madison
  • Denise R. Aberle, MD, University of California, Los Angeles
  • Mark Alan Helvie, MD, University of Michigan, Ann Arbor

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.